N
CKPT

Nuveen’s Checkpoint Therapeutics CKPT Stock Holding History

Nuveen’s Portfolio CKPT Stock Details CKPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-25,018
Closed -$786K – 3394
2021
Q1 		$786K Buy
25,018
+759
+3% +$25.4K ﹤0.01% 2969
2020
Q4 		$643K Buy
24,259
+2,834
+13% +$71.7K ﹤0.01% 2964
2020
Q3 		$575K Buy
21,425
+2,047
+11% +$49.2K ﹤0.01% 2906
2020
Q2 		$384K Buy
19,378
+9,974
+106% +$182K ﹤0.01% 2989
2020
Q1 		$142K Buy
9,404
+3,055
+48% +$54.1K ﹤0.01% 3037
2019
Q4 		$110K Hold
6,349
– – ﹤0.01% 3126
2019
Q3 		$158K Buy
6,349
+30
+0.5% +$823 ﹤0.01% 3140
2019
Q2 		$191K Buy
+6,319
New +$248K ﹤0.01% 3182

Other funds holding CKPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JSMC
Jess S. Morgan & Co Los Angeles, California $115M AUM 16.65% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SAG
Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FWM
Frontier Wealth Management Kansas City, Missouri $1.38B AUM 6.3% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return

Nuveen's CKPT Position: Q2 2021 in Review

Nuveen sold out of Checkpoint Therapeutics (CKPT) in Q2 2021, closing a stake of 25,018 shares — an estimated $786K sold.

Nuveen first reported a position in CKPT in Q2 2019 and held it in 8 quarters. The position peaked at $786K in Q1 2021. 69 funds tracked by Wall St. Rank hold CKPT as of Q2 2021.

  • Nuveen reported no remaining Checkpoint Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Nuveen sold 25,018 Checkpoint Therapeutics shares in Q2 2021, an estimated $786K.
  • Nuveen first reported a position in Checkpoint Therapeutics in Q2 2019 and held it in 8 quarters.
  • Nuveen's Checkpoint Therapeutics position peaked at $786K in Q1 2021.
  • 69 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2021.

Based on Nuveen's 13F filing for Q2 2021, filed 16 Aug 2021.